Centre For The Aids Programme Of Research In South Africa

This study tested a new HIV medication (Biktarvy) taken twice daily in 122 adults who also have drug-sensitive tuberculosis (TB) and are on standard TB treatment. The main goal was to see if the drug could suppress HIV to undetectable levels by week 24. Results help doctors under…